Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects.

MLA

He, Xuemei, et al. “Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects.” Drug Design, Development and Therapy, vol. 16, Sept. 2022, pp. 2967–80. EBSCOhost, https://doi.org/10.2147/DDDT.S372575.

APA

He, X., Gao, X., Xie, P., Liu, Y., Bai, W., Liu, Y., & Shi, A. (2022). Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects. Drug Design, Development and Therapy, 16, 2967–2980. https://doi.org/10.2147/DDDT.S372575

Chicago

He, Xuemei, Xin Gao, Panpan Xie, Yuan Liu, Wenjing Bai, Yue Liu, and Aixin Shi. 2022. “Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects.” Drug Design, Development and Therapy 16 (September): 2967–80. doi:10.2147/DDDT.S372575.